首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1818247

標靶人源化小鼠市場報告：2031 年趨勢、預測與競爭分析

Target Humanized Mice Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年09月19日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

全球標靶人源化小鼠市場前景光明，在癌症研究、免疫療法和藥物篩檢市場都蘊藏著巨大的機會。預計2025年至2031年期間，全球標靶人源化小鼠市場的複合年成長率將達8.9%。該市場的主要驅動力是個人化醫療需求的不斷成長以及基因編輯技術的不斷進步。

Lucintel 預測，在預測期內，免疫查核點點將在類型方面經歷最高的成長。
從應用來看，癌症研究預計將實現最高的成長。
按地區分類，預計亞太地區將在預測期內實現最高成長。

標靶人源化小鼠市場的新趨勢

受基因工程進步、精準醫療需求成長以及對更精準臨床前模型日益成長的需求的推動，靶向人源化小鼠市場正在快速發展。這些趨勢正在重塑生物醫學研究領域，為藥物開發、個人化醫療和疾病理解提供新的機會。以下是影響市場的五個關鍵趨勢：

基因編輯技術（例如 CRISPR）的進步：CRISPR 等基因編輯技術徹底改變了人源化小鼠的構建，使其能夠進行精準的基因改造以及整合人類細胞和組織。這些進步顯著提高了人源化小鼠模型的準確性，使其在臨床前測試中更加可靠。因此，人源化小鼠市場正在不斷擴大，使研究人員能夠創建更具特異性的模型來研究癌症、自體免疫疾病和感染疾病等疾病。
個人化醫療需求日益成長：個人化醫療是針對人源化小鼠市場的關鍵驅動力之一，人源化模型能夠更準確地預測個人對藥物的反應。隨著製藥和生物技術行業專注於開發客製化治療方法，對人源化小鼠的需求日益成長，用於研究人類特異性疾病機制和藥物反應。這一趨勢催生了對能夠模擬多種人類遺傳背景和疾病特徵的先進人源化模型的巨大需求。
擴大臨床前藥物測試：人源化小鼠正成為臨床前藥物測試的重要工具，其結果比傳統動物模型更可靠。這一趨勢源於對更能預測人體反應的高品質測試模型日益成長的需求。人源化小鼠在免疫療法、生技藥品和基因療法的測試中尤其重要。隨著臨床前測試監管要求日益嚴格，藥物開發中對人源化小鼠模型的需求預計將持續成長。
生物技術和製藥研究投資不斷增加：生物技術和製藥研究的日益成長的關注推動了對先進研究模型的需求，尤其是人源化小鼠。各國政府、學術機構和私人企業正在大力投資生命科學，推動了人源化動物模型的創新。這些投資正在推動更先進、更可靠、更具可擴展性的人源化小鼠的開發，進而加速生物醫學研究和藥物研發。
倫理考量與法規：隨著人源化小鼠應用的不斷擴展，圍繞其建構和研究使用的倫理問題也日益凸顯。這促使人們制定了更嚴格的基因改造動物使用法規和指南。研究人員目前致力於確保人源化小鼠得到負責任的使用，並最大限度地減少動物的痛苦。這一趨勢正在推動研究活動更加透明，並促進更永續、更符合倫理的模式的發展。

這些新興趨勢凸顯了標靶人源化小鼠市場的快速成長，其驅動力來自基因工程的創新、對個人化醫療的日益關注以及生物技術投資的不斷增加。這些趨勢持續演變，重塑了生物醫學研究的進行方式，並促進了更精準、更有效率的臨床前模型的發展。

標靶人源化小鼠市場的最新趨勢

近期，標靶人源化小鼠市場呈現變革性發展趨勢，這得益於基因工程的突破、藥物研發的新應用以及研究經費的增加。這些發展使得人源化小鼠成為精準醫療、疾病建模和藥物測試的關鍵工具。以下是塑造該市場的五個關鍵發展趨勢：

CRISPR-Cas9 和高級基因編輯：CRISPR-Cas9 技術的採用正在對人源化小鼠市場產生重大影響。該技術能夠實現精準高效的基因編輯，使研究人員能夠創建更準確、更貼近人類的模型。能夠高精度地將人類基因、細胞和組織導入小鼠體內，正在加速用於研究特定疾病和測試候選藥物的專用人源化小鼠的研發。
免疫腫瘤學研究與人源化小鼠：人源化小鼠在免疫腫瘤學研究中的應用日益廣泛，用於測試癌症免疫療法。這些模型能夠更好地代表人體免疫系統，從而能夠更準確地進行免疫療法和抗癌藥物的臨床前測試。免疫腫瘤學的興起推動了對人源化小鼠模型的需求，從而進一步推動了人源化小鼠模型的生產及其在癌症研究中的應用。
用於感染疾病研究的人源化小鼠：人源化小鼠在感染疾病研究中至關重要，包括HIV和茲卡病毒等病毒感染疾病。這些模型使研究人員能夠在更接近人類的環境中測試疫苗、抗病毒藥物和其他療法。隨著全球對流行病和感染疾病爆發的擔憂日益加劇，用於感染疾病研究的人源化小鼠的需求正在迅速成長。
生物技術與研究夥伴關係：生物技術公司與學術研究機構之間的合作正在推動人源化小鼠模型的開發和應用。這些夥伴關係加速了人源化小鼠的創新和商業化，擴大了其在藥物研發、疾病研究和精準醫療領域的應用。這些合作對於推動下一代人源化小鼠模型的發展至關重要。
開發更具成本效益的人源化小鼠模型：目前正在努力開發更具成本效益的人源化小鼠的生成和維持方法。這包括改進育種技術、基因改造和模型標準化。隨著對此類模型的需求不斷成長，成本效益成為首要考慮因素，以便研究機構和生物技術公司能夠更廣泛地採用此類模型。

標靶人源化小鼠市場的關鍵發展證實了這些模型在推動生物醫學研究中日益成長的重要性。基因編輯技術的創新、免疫腫瘤學研究需求的不斷成長以及產學研合作正在推動市場發展，從而推動更精準、更具成本效益、更專業的人源化小鼠模型的開發。

The future of the global target humanized mice market looks promising with opportunities in the cancer research, immunity therapy, and drug screening markets. The global target humanized mice market is expected to grow with a CAGR of 8.9% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized treatment and the rising advancement in gene editing technologies.

Lucintel forecasts that, within the type category, immune checkpoint is expected to witness the highest growth over the forecast period.
Within the application category, cancer research is expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Target Humanized Mice Market

The target humanized mice market is evolving rapidly, driven by advancements in genetic engineering, increased demand for precision medicine, and the growing need for more accurate preclinical models. These trends are reshaping the field of biomedical research, offering new opportunities for drug development, personalized medicine, and disease understanding. Below are five key trends that are influencing the market.

Advances in Gene Editing Technologies (e.g., CRISPR): Gene editing technologies like CRISPR are revolutionizing the production of humanized mice, allowing for precise modifications of genes and the incorporation of human cells or tissues. These advancements have dramatically improved the accuracy of humanized mice models, making them more reliable for preclinical testing. As a result, the market for humanized mice is expanding, with researchers able to create more specific models for disease research, including cancer, autoimmune disorders, and infectious diseases.
Growing Demand for Personalized Medicine: Personalized medicine is one of the key drivers of the target humanized mice market, as humanized models offer more accurate predictions of individual responses to drugs. As the pharmaceutical and biotechnology industries focus on developing tailored therapies, the need for humanized mice to study human-specific disease mechanisms and drug responses is growing. This trend is creating significant demand for advanced humanized models that can mimic diverse human genetic backgrounds and disease profiles.
Expansion of Preclinical Drug Testing: Humanized mice are becoming essential tools in preclinical drug testing, providing more reliable results than traditional animal models. This trend is fueled by the increasing need for high-quality testing models that can predict human responses more accurately. Humanized mice are particularly valuable in the testing of immunotherapies, biologics, and gene-based treatments. As regulatory requirements for preclinical testing become more stringent, the demand for humanized mice models in drug development is expected to continue growing.
Rising Investments in Biotech and Pharmaceutical Research: The increasing focus on biotechnology and pharmaceutical research is driving the demand for advanced research models, particularly humanized mice. Governments, academic institutions, and private enterprises are investing heavily in life sciences, resulting in a greater push for innovations in humanized animal models. These investments are leading to the development of more advanced, reliable, and scalable humanized mice, which in turn are accelerating biomedical research and drug discovery processes.
Ethical Considerations and Regulations: As the use of humanized mice expands, ethical concerns surrounding their creation and use in research are becoming more prominent. This has led to the development of stricter regulations and guidelines for using genetically modified animals. Researchers are now focused on ensuring that humanized mice are used responsibly, emphasizing minimizing animal suffering. This trend encourages the development of more sustainable and ethical models with greater transparency in research practices.

These emerging trends highlight the rapid growth of the target humanized mice market, fueled by innovations in genetic engineering, a growing emphasis on personalized medicine, and increased investments in biotechnology. As these trends continue to evolve, they are reshaping how biomedical research is conducted and driving the development of more accurate and efficient preclinical models.

Recent Developments in the Target Humanized Mice Market

Recent developments in the target humanized mice market have been transformative, with breakthroughs in genetic engineering, new applications in drug discovery, and increased research funding. These developments are positioning humanized mice as critical tools in precision medicine, disease modeling, and drug testing. Below are five key developments that are shaping the market.

CRISPR-Cas9 and Advanced Genetic Editing: The adoption of CRISPR-Cas9 technology has significantly impacted the humanized mice market. This technology allows for precise and efficient gene editing, enabling researchers to create more accurate and human-relevant models. The ability to introduce human genes, cells, or tissues into mice with high precision has accelerated the creation of specialized humanized mice for studying specific diseases and testing new drug candidates.
Immuno-oncology Research and Humanized Mice: Humanized mice are increasingly being used in immuno-oncology research to test cancer immunotherapies. These models are more representative of human immune systems, allowing for more accurate preclinical testing of immunotherapies and cancer drugs. The rise of immuno-oncology has driven demand for humanized mice models, leading to further developments in their production and application in cancer research.
Humanized Mice for Infectious Disease Research: Humanized mice have become crucial in the study of infectious diseases, including viral infections like HIV and Zika virus. These models offer researchers the ability to test vaccines, antivirals, and other therapeutic agents in a more human-like context. With the rising global concern over pandemics and infectious disease outbreaks, the demand for humanized mice for infectious disease research has grown rapidly.
Partnerships Between Biotech Companies and Research Institutions: Collaborations between biotech companies and academic research institutions have led to advancements in the development and application of humanized mice models. These partnerships are accelerating the innovation and commercialization of humanized mice, expanding their use in drug discovery, disease research, and precision medicine. These collaborations are crucial for advancing the next generation of humanized mouse models.
Development of More Cost-Effective Humanized Mouse Models: There has been a push towards developing more cost-effective methods for creating and maintaining humanized mice. This includes improvements in breeding techniques, genetic modifications, and model standardization. As demand for these models increases, cost-effectiveness becomes a priority, allowing for broader adoption across research institutions and biotech companies.

The key developments in the target humanized mice market underscore the growing importance of these models in advancing biomedical research. Innovations in genetic editing, increased demand for immuno-oncology research, and partnerships between industry and academia are driving the market forward, leading to the development of more accurate, cost-effective, and specialized humanized mice models.

Strategic Growth Opportunities in the Target Humanized Mice Market

The target humanized mice market offers several growth opportunities across a variety of applications, driven by advancements in genetic engineering and the increasing need for precision models in drug testing and disease research. Below are five key growth opportunities by application that are shaping the future of the market.

Cancer Drug Discovery: Humanized mice models are essential for the development and testing of cancer drugs, especially in immuno-oncology. As the focus on immunotherapy and personalized cancer treatments grows, the demand for humanized mouse models in this field is expected to increase. This presents significant growth opportunities for companies involved in the production and development of humanized mice tailored for cancer research.
Personalized Medicine: With the increasing focus on personalized medicine, there is a growing need for humanized mice models that can simulate specific human disease conditions. These models can be used to test individualized therapies, including gene therapies and targeted drugs. The demand for precision medicine is expected to drive the market for humanized mice, offering new growth avenues for model development and customization.
Regenerative Medicine Research: Humanized mice models are being used to study regenerative medicine, particularly in areas like stem cell research and tissue engineering. These models provide insights into human tissue regeneration and repair mechanisms, supporting the development of regenerative therapies. This growing field offers substantial opportunities for the application of humanized mice in research.
Infectious Disease Drug Development: The need for more accurate models to study infectious diseases, such as viral infections, is driving the growth of humanized mice in this application. Humanized models are becoming crucial tools for testing vaccines and antiviral therapies. This market segment is expected to expand as the demand for infectious disease treatments continues to rise.
Toxicology and Safety Testing: Humanized mice models are increasingly being used in toxicology studies for drug safety testing. These models provide more relevant data on human drug responses, reducing the risks associated with human clinical trials. As regulatory agencies demand more human-relevant testing methods, the use of humanized mice in safety testing is expected to grow.

The strategic growth opportunities in the target humanized mice market are diverse, spanning cancer research, personalized medicine, regenerative therapies, infectious diseases, and safety testing. These applications are driving innovation in the market, with humanized mice models playing a critical role in advancing drug discovery and biomedical research.

Target Humanized Mice Market Driver and Challenges

The target humanized mice market is influenced by a range of technological, economic, and regulatory factors. Advances in biotechnology and genetic engineering have driven the development of humanized mouse models, which are essential for drug discovery and immunology research. Economic trends, such as increasing investment in life sciences and healthcare, further stimulate market growth. At the same time, regulatory factors, including ethical guidelines and animal welfare regulations, present challenges. Understanding the key drivers and challenges impacting this market is crucial for stakeholders to navigate the evolving landscape and harness the potential of humanized mice in biomedical research.

The factors responsible for driving the target humanized mice market include:

1. Advances in Biotechnology and Genetic Engineering: Technological advancements in biotechnology and genetic engineering are a major driver for the target humanized mice market. The development of more precise gene-editing technologies, such as CRISPR, has significantly improved the creation of humanized mouse models. These models are increasingly able to mimic human diseases more accurately, enhancing their utility in drug discovery, immunotherapy, and cancer research. As research requires more advanced and reliable animal models, the demand for humanized mice continues to rise, driving market growth and innovation in genetic engineering techniques.

2. Growing Pharmaceutical and Biotechnology Investments: The increasing investment in the pharmaceutical and biotechnology industries plays a critical role in driving demand for Target Humanized Mice. As drug discovery and development become more complex, humanized mice models are crucial in testing the efficacy and safety of new treatments. These models provide more reliable results than traditional animal models, accelerating the development process and reducing the time and cost of clinical trials. With growing investments in personalized medicine and immunotherapies, the need for humanized mice continues to expand, fostering growth in the market.

3. Demand for More Accurate Preclinical Models: There is a growing demand for more accurate and reliable preclinical models to improve the predictability of drug responses in humans. Traditional animal models often fail to replicate human physiology and disease mechanisms effectively, leading to high failure rates in clinical trials. Humanized mice, however, are better equipped to simulate human immune systems and disease conditions, providing more accurate data in preclinical testing. As a result, researchers and pharmaceutical companies are increasingly turning to humanized mice, driving market growth and the demand for innovative, high-quality models.

4. Increasing Focus on Immunotherapy and Personalized Medicine: The growing focus on immunotherapy and personalized medicine has significantly impacted the target humanized mice market. Humanized mice are invaluable in studying immune responses, cancer therapies, and the development of personalized treatment regimens. These models allow researchers to test therapies that are tailored to individual genetic profiles, improving treatment outcomes. With the rise of immuno-oncology and other targeted therapies, the demand for humanized mouse models to evaluate new treatments is expected to continue expanding, further driving market growth in the coming years.

5. Expansion of Healthcare Research and Clinical Trials: The expansion of healthcare research and clinical trials has led to a higher demand for humanized mice in preclinical testing. As healthcare research accelerates globally, there is an increasing need for reliable animal models that can mimic human disease and treatment responses accurately. Humanized mice provide the necessary tools for testing a wide range of therapeutic strategies, especially in oncology, immunology, and infectious diseases. The increasing number of clinical trials and research projects globally ensures the sustained growth of the humanized mice market as researchers continue to prioritize these models for their clinical relevance.

Challenges in the target humanized mice market are:

1. Ethical and Regulatory Concerns: Ethical and regulatory concerns surrounding the use of animals in research represent a significant challenge in the target humanized mice market. Stricter animal welfare regulations are being implemented globally, leading to greater scrutiny of the use of animal models in biomedical research. Researchers and companies must comply with ethical guidelines, such as the 3Rs (Replacement, Reduction, and Refinement), to minimize animal use and suffering. These regulations can increase the cost and complexity of developing and maintaining humanized mice models, as well as create potential delays in research timelines.

2. High Cost of Development and Maintenance: The development and maintenance of humanized mice models are expensive and resource-intensive. Producing humanized mice requires advanced genetic engineering techniques, specialized facilities, and highly skilled personnel, making them more costly than traditional animal models. Additionally, maintaining the health and genetic integrity of these mice over time requires significant investment in breeding, care, and monitoring. The high cost of development and maintenance may limit access to these models for smaller research institutions and companies, hindering widespread adoption and slowing market growth in some regions.

3. Limited Availability of Suitable Models: Another key challenge is the limited availability of suitable humanized mouse models for specific research needs. While significant progress has been made, the process of humanizing mice to accurately represent human diseases is still complex and resource-heavy. Researchers may find it difficult to access models that match specific disease conditions or genetic variations, limiting their ability to perform targeted research. This shortage of suitable models can delay research progress and restrict the potential applications of humanized mice, impacting market growth and the development of innovative therapies.

The target humanized mice market is driven by technological advancements in biotechnology, increasing investments in pharmaceutical and biotech industries, and a growing need for more accurate preclinical models. The expansion of immunotherapy and personalized medicine further fuels demand, alongside the increasing focus on healthcare research and clinical trials. However, challenges such as ethical and regulatory concerns, high development costs, and limited availability of specific models present hurdles to market growth. Navigating these challenges while leveraging the drivers will be essential for stakeholders to maximize the potential of humanized mice in advancing biomedical research and drug development.

List of Target Humanized Mice Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies target humanized mice companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the target humanized mice companies profiled in this report include-

Charles River
Jackson Laboratory
Taconic Biosciences
Gempharmatech
Vitalstar Biotechnology
GenOway
Hanheng Biotechnology
Cyagen Biosciences
Beijing Biocytogen
Shanghai Model Organisms Center

Target Humanized Mice Market by Segment

The study includes a forecast for the global target humanized mice market by type, application, and region.

Target Humanized Mice Market by Type [Value from 2019 to 2031]:

Tumor Target
Immune Checkpoint
Complement System Targets
Metabolic Target
Other

Target Humanized Mice Market by Application [Value from 2019 to 2031]:

Cancer Research
Immunity Therapy
Drug Screening

Target Humanized Mice Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Target Humanized Mice Market

United States: In the United States, the target humanized mice market has witnessed a surge in demand due to the country's dominance in biomedical research. Major pharmaceutical companies and biotech firms are investing heavily in humanized mouse models for preclinical testing, particularly for immunotherapies and personalized medicine. Additionally, collaborations between research institutions and private companies are accelerating advancements in genetically modified models that better mimic human disease conditions. The U.S. also leads in the development of advanced technologies for creating humanized mice, with significant contributions from gene-editing tools like CRISPR, driving the market forward.
China: China is rapidly expanding its presence in the target humanized mice market, leveraging its large-scale manufacturing capabilities and research-driven approach. The country has seen a significant rise in biotech firms focused on producing humanized mice for drug discovery, particularly in cancer and autoimmune diseases. With growing investment in life sciences and a focus on biotechnology innovation, China is positioning itself as a competitive player in the market. Additionally, the government is actively supporting the biotechnology sector, fostering collaborations with international firms to advance humanized mouse technology and research outcomes.
Germany: Germany's contributions to the target humanized mice market are largely driven by its strong research institutions and expertise in biomedical sciences. The country is a leader in genetic engineering techniques and has made significant progress in developing highly specialized humanized mouse models for studying complex diseases like Alzheimer's and cancer. German research institutions collaborate with major pharmaceutical companies to create more accurate models for drug testing and development. Germany is also focusing on the ethical considerations surrounding the use of humanized animals, ensuring that new models are not only scientifically advanced but also meet ethical standards for animal welfare.
India: India is emerging as a growing player in the target humanized mice market, largely driven by increasing research investments in biomedical sciences. The demand for humanized mice models is rising as Indian researchers focus on personalized medicine and disease-specific therapies. With the expansion of biotechnology hubs in cities like Bangalore and Hyderabad, India is witnessing greater collaboration between academic institutions, pharmaceutical companies, and CROs (Contract Research Organizations). The cost-effectiveness of Indian research services, along with government support for biotech innovation, is accelerating the adoption of humanized mice models in the region.
Japan: Japan has been at the forefront of advanced genetic research, and its contributions to the target humanized mice market reflect its leadership in biotechnological innovation. Japanese companies and universities are increasingly using humanized mice to study diseases like cancer, cardiovascular conditions, and infectious diseases. The market is growing as Japanese researchers focus on improving the accuracy and efficiency of humanized models, incorporating new genetic technologies to replicate human disease more effectively. Additionally, Japan's emphasis on ethical and sustainable scientific practices ensures the responsible use of humanized animals in research.

Features of the Global Target Humanized Mice Market

Market Size Estimates: Target humanized mice market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Target humanized mice market size by type, application, and region in terms of value ($B).
Regional Analysis: Target humanized mice market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the target humanized mice market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the target humanized mice market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the target humanized mice market by type (tumor target, immune checkpoint, complement system targets, metabolic target, and other), application (cancer research, immunity therapy, and drug screening), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Target Humanized Mice Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Tumor Target: Trends and Forecast (2019-2031)
4.4 Immune Checkpoint: Trends and Forecast (2019-2031)
4.5 Complement System Targets: Trends and Forecast (2019-2031)
4.6 Metabolic Target: Trends and Forecast (2019-2031)
4.7 Other: Trends and Forecast (2019-2031)

5. Global Target Humanized Mice Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Cancer Research: Trends and Forecast (2019-2031)
5.4 Immunity Therapy: Trends and Forecast (2019-2031)
5.5 Drug Screening: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Target Humanized Mice Market by Region

7. North American Target Humanized Mice Market

7.1 Overview
7.2 North American Target Humanized Mice Market by Type
7.3 North American Target Humanized Mice Market by Application
7.4 United States Target Humanized Mice Market
7.5 Mexican Target Humanized Mice Market
7.6 Canadian Target Humanized Mice Market

8. European Target Humanized Mice Market

8.1 Overview
8.2 European Target Humanized Mice Market by Type
8.3 European Target Humanized Mice Market by Application
8.4 German Target Humanized Mice Market
8.5 French Target Humanized Mice Market
8.6 Spanish Target Humanized Mice Market
8.7 Italian Target Humanized Mice Market
8.8 United Kingdom Target Humanized Mice Market

9. APAC Target Humanized Mice Market

9.1 Overview
9.2 APAC Target Humanized Mice Market by Type
9.3 APAC Target Humanized Mice Market by Application
9.4 Japanese Target Humanized Mice Market
9.5 Indian Target Humanized Mice Market
9.6 Chinese Target Humanized Mice Market
9.7 South Korean Target Humanized Mice Market
9.8 Indonesian Target Humanized Mice Market

10. ROW Target Humanized Mice Market

10.1 Overview
10.2 ROW Target Humanized Mice Market by Type
10.3 ROW Target Humanized Mice Market by Application
10.4 Middle Eastern Target Humanized Mice Market
10.5 South American Target Humanized Mice Market
10.6 African Target Humanized Mice Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Target Humanized Mice Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Charles River
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Jackson Laboratory
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Taconic Biosciences
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Gempharmatech
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Vitalstar Biotechnology
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 GenOway
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Hanheng Biotechnology
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.9 Cyagen Biosciences
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.10 Beijing Biocytogen
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.11 Shanghai Model Organisms Center
- Company Overview
- Target Humanized Mice Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

簡介目錄圖表

List of Figures

Figure 1.1: Trends and Forecast for the Global Target Humanized Mice Market
Figure 2.1: Usage of Target Humanized Mice Market
Figure 2.2: Classification of the Global Target Humanized Mice Market
Figure 2.3: Supply Chain of the Global Target Humanized Mice Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Target Humanized Mice Market
Figure 4.1: Global Target Humanized Mice Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Target Humanized Mice Market ($B) by Type
Figure 4.3: Forecast for the Global Target Humanized Mice Market ($B) by Type
Figure 4.4: Trends and Forecast for Tumor Target in the Global Target Humanized Mice Market (2019-2031)
Figure 4.5: Trends and Forecast for Immune Checkpoint in the Global Target Humanized Mice Market (2019-2031)
Figure 4.6: Trends and Forecast for Complement System Targets in the Global Target Humanized Mice Market (2019-2031)
Figure 4.7: Trends and Forecast for Metabolic Target in the Global Target Humanized Mice Market (2019-2031)
Figure 4.8: Trends and Forecast for Other in the Global Target Humanized Mice Market (2019-2031)
Figure 5.1: Global Target Humanized Mice Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Target Humanized Mice Market ($B) by Application
Figure 5.3: Forecast for the Global Target Humanized Mice Market ($B) by Application
Figure 5.4: Trends and Forecast for Cancer Research in the Global Target Humanized Mice Market (2019-2031)
Figure 5.5: Trends and Forecast for Immunity Therapy in the Global Target Humanized Mice Market (2019-2031)
Figure 5.6: Trends and Forecast for Drug Screening in the Global Target Humanized Mice Market (2019-2031)
Figure 6.1: Trends of the Global Target Humanized Mice Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Target Humanized Mice Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Target Humanized Mice Market (2019-2031)
Figure 7.2: North American Target Humanized Mice Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Target Humanized Mice Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Target Humanized Mice Market ($B) by Type (2025-2031)
Figure 7.5: North American Target Humanized Mice Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Target Humanized Mice Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Target Humanized Mice Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Target Humanized Mice Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Target Humanized Mice Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Target Humanized Mice Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Target Humanized Mice Market (2019-2031)
Figure 8.2: European Target Humanized Mice Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Target Humanized Mice Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Target Humanized Mice Market ($B) by Type (2025-2031)
Figure 8.5: European Target Humanized Mice Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Target Humanized Mice Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Target Humanized Mice Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Target Humanized Mice Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Target Humanized Mice Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Target Humanized Mice Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Target Humanized Mice Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Target Humanized Mice Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Target Humanized Mice Market (2019-2031)
Figure 9.2: APAC Target Humanized Mice Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Target Humanized Mice Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Target Humanized Mice Market ($B) by Type (2025-2031)
Figure 9.5: APAC Target Humanized Mice Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Target Humanized Mice Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Target Humanized Mice Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Target Humanized Mice Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Target Humanized Mice Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Target Humanized Mice Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Target Humanized Mice Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Target Humanized Mice Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Target Humanized Mice Market (2019-2031)
Figure 10.2: ROW Target Humanized Mice Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Target Humanized Mice Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Target Humanized Mice Market ($B) by Type (2025-2031)
Figure 10.5: ROW Target Humanized Mice Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Target Humanized Mice Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Target Humanized Mice Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Target Humanized Mice Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Target Humanized Mice Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Target Humanized Mice Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Target Humanized Mice Market
Figure 11.2: Market Share (%) of Top Players in the Global Target Humanized Mice Market (2024)
Figure 12.1: Growth Opportunities for the Global Target Humanized Mice Market by Type
Figure 12.2: Growth Opportunities for the Global Target Humanized Mice Market by Application
Figure 12.3: Growth Opportunities for the Global Target Humanized Mice Market by Region
Figure 12.4: Emerging Trends in the Global Target Humanized Mice Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Target Humanized Mice Market by Type and Application
Table 1.2: Attractiveness Analysis for the Target Humanized Mice Market by Region
Table 1.3: Global Target Humanized Mice Market Parameters and Attributes
Table 3.1: Trends of the Global Target Humanized Mice Market (2019-2024)
Table 3.2: Forecast for the Global Target Humanized Mice Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Target Humanized Mice Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Target Humanized Mice Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Target Humanized Mice Market (2025-2031)
Table 4.4: Trends of Tumor Target in the Global Target Humanized Mice Market (2019-2024)
Table 4.5: Forecast for Tumor Target in the Global Target Humanized Mice Market (2025-2031)
Table 4.6: Trends of Immune Checkpoint in the Global Target Humanized Mice Market (2019-2024)
Table 4.7: Forecast for Immune Checkpoint in the Global Target Humanized Mice Market (2025-2031)
Table 4.8: Trends of Complement System Targets in the Global Target Humanized Mice Market (2019-2024)
Table 4.9: Forecast for Complement System Targets in the Global Target Humanized Mice Market (2025-2031)
Table 4.10: Trends of Metabolic Target in the Global Target Humanized Mice Market (2019-2024)
Table 4.11: Forecast for Metabolic Target in the Global Target Humanized Mice Market (2025-2031)
Table 4.12: Trends of Other in the Global Target Humanized Mice Market (2019-2024)
Table 4.13: Forecast for Other in the Global Target Humanized Mice Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Target Humanized Mice Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Target Humanized Mice Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Target Humanized Mice Market (2025-2031)
Table 5.4: Trends of Cancer Research in the Global Target Humanized Mice Market (2019-2024)
Table 5.5: Forecast for Cancer Research in the Global Target Humanized Mice Market (2025-2031)
Table 5.6: Trends of Immunity Therapy in the Global Target Humanized Mice Market (2019-2024)
Table 5.7: Forecast for Immunity Therapy in the Global Target Humanized Mice Market (2025-2031)
Table 5.8: Trends of Drug Screening in the Global Target Humanized Mice Market (2019-2024)
Table 5.9: Forecast for Drug Screening in the Global Target Humanized Mice Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Target Humanized Mice Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Target Humanized Mice Market (2025-2031)
Table 7.1: Trends of the North American Target Humanized Mice Market (2019-2024)
Table 7.2: Forecast for the North American Target Humanized Mice Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Target Humanized Mice Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Target Humanized Mice Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Target Humanized Mice Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Target Humanized Mice Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Target Humanized Mice Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Target Humanized Mice Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Target Humanized Mice Market (2019-2031)
Table 8.1: Trends of the European Target Humanized Mice Market (2019-2024)
Table 8.2: Forecast for the European Target Humanized Mice Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Target Humanized Mice Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Target Humanized Mice Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Target Humanized Mice Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Target Humanized Mice Market (2025-2031)
Table 8.7: Trends and Forecast for the German Target Humanized Mice Market (2019-2031)
Table 8.8: Trends and Forecast for the French Target Humanized Mice Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Target Humanized Mice Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Target Humanized Mice Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Target Humanized Mice Market (2019-2031)
Table 9.1: Trends of the APAC Target Humanized Mice Market (2019-2024)
Table 9.2: Forecast for the APAC Target Humanized Mice Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Target Humanized Mice Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Target Humanized Mice Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Target Humanized Mice Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Target Humanized Mice Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Target Humanized Mice Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Target Humanized Mice Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Target Humanized Mice Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Target Humanized Mice Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Target Humanized Mice Market (2019-2031)
Table 10.1: Trends of the ROW Target Humanized Mice Market (2019-2024)
Table 10.2: Forecast for the ROW Target Humanized Mice Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Target Humanized Mice Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Target Humanized Mice Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Target Humanized Mice Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Target Humanized Mice Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Target Humanized Mice Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Target Humanized Mice Market (2019-2031)
Table 10.9: Trends and Forecast for the African Target Humanized Mice Market (2019-2031)
Table 11.1: Product Mapping of Target Humanized Mice Suppliers Based on Segments
Table 11.2: Operational Integration of Target Humanized Mice Manufacturers
Table 11.3: Rankings of Suppliers Based on Target Humanized Mice Revenue
Table 12.1: New Product Launches by Major Target Humanized Mice Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Target Humanized Mice Market

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球萊茵衣藻粉市場（按類型、純度等級、應用、最終用戶和地區）：趨勢分析、競爭格局和未來預測（2019-2031）

低溫儲存設備市場分析及2034年預測：類型、產品、服務、技術、組件、應用、材料類型、最終用戶、流程

衣藻的全球市場(2024年)

FAQ

標靶人源化小鼠市場報告：2031 年趨勢、預測與競爭分析

Target Humanized Mice Market Report: Trends, Forecast and Competitive Analysis to 2031

目錄

第1章執行摘要

第2章市場概況

第3章：市場趨勢及預測分析

4. 全球標靶人源化小鼠市場（按類型）

5. 全球標靶人源化小鼠市場（依應用）

第6章區域分析

7. 北美標靶人源化小鼠市場

8. 歐洲目標人源化小鼠市場

9. 亞太地區人源化小鼠目標市場

10. 世界其他地區的人源化小鼠市場

第11章競爭分析

第12章：機會與策略分析

第13章價值鏈主要企業的公司簡介

第14章附錄

Target Humanized Mice Market by Type [Value from 2019 to 2031]:

Target Humanized Mice Market by Application [Value from 2019 to 2031]:

Target Humanized Mice Market by Region [Value from 2019 to 2031]:

This report answers following 11 key questions: